Resumen de First Drug In A New Class Treats Type 2 Diabetes

Diane S. Aschenbrenner

• * Canagliflozin (Invokana) is the first drug in a new class approved for the treatment of type 2 diabetes.

  * It promotes the renal excretion of glucose and, consequently, diuresis; as a result, patients can develop hypovolemia and hypotension.

  * Canagliflozin should be avoided in patients with serious renal insufficiency.